These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28284335)

  • 1. Oxidative modifications of blood serum proteins in myasthenia gravis.
    Adamczyk-Sowa M; Bieszczad-Bedrejczuk E; Galiniak S; Rozmiłowska I; Czyżewski D; Bartosz G; Sadowska-Bartosz I
    J Neuroimmunol; 2017 Apr; 305():145-153. PubMed ID: 28284335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
    Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
    Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
    Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
    Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis of thymectomy in treatment of ocular myasthenia gravis and relevant influencing factors].
    Deng Y; Zhang X
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(27):1922-5. PubMed ID: 19953918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
    Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
    Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular versus generalized myasthenia gravis: a continuum associated with acetylcholine receptor antibody titers.
    Axelsen KH; Kjær Andersen R; Andersen LK; Vissing J; Witting N
    Neuromuscul Disord; 2024 Oct; 43():39-43. PubMed ID: 39190980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.
    Zhang Y; Zhang X; Xia Y; Jia X; Li H; Zhang Y; Shao Z; Xin N; Guo M; Chen J; Zheng S; Wang Y; Fu L; Xiao C; Geng D; Liu Y; Cui G; Dong R; Huang X; Yu T
    Immunol Res; 2016 Dec; 64(5-6):1216-1224. PubMed ID: 27677768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of transcription factors IRF4 and IRF8 in peripheral blood B cells is associated with clinical severity and circulating plasma cells frequency in patients with myasthenia gravis.
    Zhang Y; Jia X; Xia Y; Li H; Chen F; Zhu J; Zhang X; Zhang Y; Wang Y; Xu Y; Pan M; Huang X; Yu T; Fu L; Xiao C; Geng D
    Autoimmunity; 2018 May; 51(3):126-134. PubMed ID: 29569949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
    Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
    J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases.
    Guan YZ; Cui LY; Liu MS; Niu JW
    Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to treatment in pediatric ocular myasthenia gravis.
    Xu L; Castro D; Reisch JS; Iannaccone ST
    Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low conversion rate of ocular to generalized myasthenia gravis in Singapore.
    Teo KY; Tow SL; Haaland B; Gosavi TD; Jing-Liang L; Yew Long LO; Milea D
    Muscle Nerve; 2018 May; 57(5):756-760. PubMed ID: 28981152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Ocular Myasthenia Gravis in an Argentinian Population.
    Aguirre F; Villa AM
    Eur Neurol; 2018; 79(3-4):113-117. PubMed ID: 29428956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases in myasthenia gravis.
    Helgeland G; Petzold A; Luckman SP; Gilhus NE; Plant GT; Romi FR
    Eur Neurol; 2011; 65(1):53-8. PubMed ID: 21212676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
    Allen JA; Scala S; Jones HR
    Muscle Nerve; 2010 Mar; 41(3):379-84. PubMed ID: 19918767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study.
    Hendricks TM; Bhatti MT; Hodge DO; Chen JJ
    Am J Ophthalmol; 2019 Sep; 205():99-105. PubMed ID: 31077669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
    Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
    Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.